Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Pfizer, Zhejiang Hisun sign JV to develop, manufacture, and sell branded generics; Pfizer sells off stake

Executive Summary

Pfizer Inc. and Chinese pharmaco Zhejiang Hisun Pharmaceutical Co. Ltd. seek to create the joint venture named Hisun-Pfizer Pharmaceuticals Co. Ltd., which will develop, manufacture, and commercialize off-patent pharmaceutical products in China and other markets worldwide. The partners signed a memorandum of understanding in June 2011.
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Generic Drugs
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Equity
    • Joint Venture
    • R&D and Marketing (Licensing)

Related Companies